Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-,monoacetate
CAS : 54143-56-5
Ref. IN-DA01CB99
1g | Arrêté | ||
10g | Arrêté | ||
10mg | Arrêté | ||
50mg | Arrêté | ||
250mg | Arrêté |
Informations sur le produit
Nom :
Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-,monoacetate
Synonymes :
- [u'Apocard', u'Fl\xe9ca\xefne', u'Flecadura', u'Flecainid Isis', u'Flecainid-Isis', u'Flecainide', u'Flecainide Acetate', u'Flecainide Monoacetate', u'Flecainide Monoacetate, (+-)-Isomer', u'Flecainide Monoacetate, (R)-Isomer', u'Flecainide Monoacetate, (S)-Isomer', u'Flecainide, (R)-Isomer', u'Flecainide, (S)-Isomer', u'Flecainide, 5-HO-N-(6-oxo)-Derivative', u'Flecainide, 5-HO-N-(6-oxo)-Derivative, (+-)-Isomer', u'Flecatab', u'R818', u'Tambocor', u'Flecainide acetate', u'54143-56-5', u'Tambocor', u'Flecainide (acetate)', u'FLECAINIDE MONOACETATE', u'Flecainide acetate salt', u'R 818', u'R-818', u'EINECS 258-997-5', u'MFCD00214290', u'MLS000069675', u'CHEBI:5091', u'N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate', u'N-(Piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate', u'SMR000058451', u'EN300-51344', u'2,5-Bis-(2,2,2-trifluoroethoxy)-N-(2-piperidinylmethyl)benzamide acetate', u'N-(2-Piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate', u'n-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide acetate', u'C19H24F6N2O5', u'N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide acetate', u'N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide acetate salt', u'N-(piperidin-2-ylmethyl)-2,5-bis[(2,2,2-trifluoroethyl)oxy]benzamide acetate', u'SR-01000000172', u'Flecainidacetat', u'Apocard', u'Flecainide acetate [USAN:JAN]', u'Tambocor (TN)', u'Flecainide acetate [USAN:USP:JAN]', u'AC1Q2BPX', u'DSSTox_CID_626', u'Opera_ID_1587', u'AC1L24WV', u'AC1Q5SY7', u'CAS-54143-56-5', u'DSSTox_RID_75700', u'DSSTox_GSID_20626', u'MLS001148177', u'MLS002222300', u'SCHEMBL121583', u'CHEMBL1200822', u'DTXSID8020626', u'CTK1H0162', u'Flecainide acetate (JP17/USP)', u'RKXNZRPQSOPPRN-UHFFFAOYSA-N', u'HMS1570C12', u'HMS2097C12', u'HMS2231E15', u'HMS3259F11', u'HMS3267N04', u'HMS3369M07', u'HMS3676D09', u'HMS3714C12', u'BCP17825', u'Tox21_200208', u'GP3700', u'AKOS015889993', u'API0002710', u'CCG-220735', u'CS-1400', u'LS-7398', u'NC00641', u'SB19142', u'NCGC00093934-01', u'NCGC00093934-02', u'NCGC00257762-01', u'AS-11702', u'CC-28437', u'CPD000058451', u'HY-17429', u'SAM002548968', u'EU-0100546', u'FT-0630667', u'D00638', u'E-0735', u'F 6777', u'J10389', u'W-5090', u'143F565', u'SR-01000000172-2', u'SR-01000000172-4', u'SR-01000000172-5', u'SR-01000000172-7', u'Flecainide acetate, British Pharmacopoeia (BP) Reference Standard', u'Flecainide acetate, European Pharmacopoeia (EP) Reference Standard', u'2,5-bis(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)benzamide acetate', u'Flecainide acetate, United States Pharmacopeia (USP) Reference Standard', u'2-({[2,5-bis(2,2,2-trifluoroethoxy)benzoyl]amino}methyl)piperidinium acetate', u'acetic acid; N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide', u'acetic acid;N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide', u'Flecainide for system suitability, European Pharmacopoeia (EP) Reference Standard', u'N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide; acetic acid', u'flecainide', u'FLECAINIDEACETATE', u'UNII-M8U465Q1WQ', u'M8U465Q1WQ']
- 2,5-Bis(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)benzamide acetate
- 2,5-Bis-(2,2,2-trifluoroethoxy)-N-(2-piperidinylmethyl)benzamide acetate
- Almarytm
- Apocard
- Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-, acetate (1:1)
- Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-, monoacetate
- Ecrinal
- Flecainide acetate [USAN:JAN]
- Flecainide monoacetate
- Voir d'autres synonymes
- N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate
- N-(2-Piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate
- N-(Piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate
- N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide acetate (1:1)
- R 818
- R 818 (pharmaceutical)
- Tambocor
- Unii-M8U465Q1Wq
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Indagoo
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
474.3947
Formule :
C19H24F6N2O5
Degré de pureté :
98%
Couleur/Forme :
Solid
InChI :
InChI=1S/C17H20F6N2O3.C2H4O2/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11;1-2(3)4/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26);1H3,(H,3,4)
Code InChI :
RKXNZRPQSOPPRN-UHFFFAOYSA-N
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :